• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国2003 - 2009年膳食补充剂广告中结构-功能声明的审查

An examination of structure-function claims in dietary supplement advertising in the U.S.: 2003-2009.

作者信息

Avery Rosemary J, Eisenberg Matthew D, Cantor Jonathan H

机构信息

Department of Policy Analysis and Management, Cornell University, Ithaca, NY 14853, United States.

Department of Health Policy and Management, Johns Hopkins University, Baltimore, MD 21205, United States.

出版信息

Prev Med. 2017 Apr;97:86-92. doi: 10.1016/j.ypmed.2017.01.008. Epub 2017 Jan 21.

DOI:10.1016/j.ypmed.2017.01.008
PMID:28115209
Abstract

Dietary supplement advertising cannot claim a causal link between the product and the treatment, prevention, or cure of a disease unless manufacturers seek approval from the FDA for a health claim. Manufacturers can make structure-function (S-F) claims without FDA approval linking a supplement to a body function or system using words such as "may help" or "promotes." These S-F claims are examined in this study in order to determine whether they mimic health claims for which the FDA requires stricter scientific evidence. Data include S-F claims in supplement advertisements (N=6179) appearing in US nationally circulated magazines (N=137) from 2003 to 2009. All advertisements were comprehensively coded for S-F claims, seals of approval, and other claims of guarantee. S-F claims associate supplements with a wide variety of health conditions, many of which are serious diseases and/or ailments. A significant number of the specific verbs used in these S-F claims are indicative of disease treatment/cure effects, thereby possibly mimicking health claims to the average consumer. The strength of the clinical associations made are largely unsubstantiated in the medical literature. Claims that a product is "scientifically proven" or "guaranteed" were largely unsubstantiated by clinical literature. Ads carrying externally validating seals of approval were highly prevalent. S-F claims that strongly mimic FDA-prohibited health claims are likely to create confusion in interpretation and possible public health concerns are discussed.

摘要

除非制造商寻求美国食品药品监督管理局(FDA)对健康声明的批准,否则膳食补充剂广告不能宣称产品与疾病的治疗、预防或治愈之间存在因果关系。制造商可以在未经FDA批准的情况下做出结构-功能(S-F)声明,将补充剂与身体功能或系统联系起来,使用“可能有助于”或“促进”等词汇。本研究对这些S-F声明进行了审查,以确定它们是否模仿了FDA要求更严格科学证据的健康声明。数据包括2003年至2009年在美国全国发行的杂志(n = 137)上出现的补充剂广告中的S-F声明(n = 6179)。所有广告都针对S-F声明、批准印章和其他保证声明进行了全面编码。S-F声明将补充剂与各种各样的健康状况联系起来,其中许多是严重疾病和/或疾病。这些S-F声明中使用的大量特定动词表明了疾病治疗/治愈效果,从而可能会让普通消费者误以为是健康声明。这些声明所建立的临床关联强度在医学文献中大多未经证实。声称产品“经过科学验证”或“有保证”的说法在临床文献中大多没有依据。带有外部有效批准印章的广告非常普遍。讨论了那些强烈模仿FDA禁止的健康声明的S-F声明可能会在解释上造成混淆以及可能引发的公共卫生问题。

相似文献

1
An examination of structure-function claims in dietary supplement advertising in the U.S.: 2003-2009.美国2003 - 2009年膳食补充剂广告中结构-功能声明的审查
Prev Med. 2017 Apr;97:86-92. doi: 10.1016/j.ypmed.2017.01.008. Epub 2017 Jan 21.
2
Dietary supplement labeling and advertising claims: are clinical studies on the full product required?膳食补充剂标签和广告宣称:是否需要对完整产品进行临床研究?
Food Drug Law J. 2009;64(1):43-67.
3
Label claims for foods and supplements: a review of the regulations.食品和补充剂的标签声明:法规综述
Nutr Clin Pract. 2005 Feb;20(1):21-32. doi: 10.1177/011542650502000121.
4
Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.膳食补充剂广告监管:联邦贸易委员会、食品药品监督管理局和全国广告部目前关注的宣称内容
Food Drug Law J. 2007;62(4):709-25.
5
Health claims and other health-related statements in the labeling and advertising of alcohol beverages (99R-199P). Final rule, Treasury decision.酒精饮料标签和广告中的健康声明及其他与健康相关的陈述(99R - 199P)。最终规则,财政部决定。
Fed Regist. 2003 Mar 3;68(41):10075-106.
6
Herbal cancer cures on the Web: noncompliance with The Dietary Supplement Health and Education Act.网络上的草药癌症疗法:不符合《膳食补充剂健康与教育法》。
Fam Med. 2002 Jul-Aug;34(7):522-7.
7
Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule.关于膳食补充剂对人体结构或功能影响的声明规定。美国卫生与公众服务部食品药品监督管理局。最终规则。
Fed Regist. 2000 Jan 6;65(4):1000-50.
8
US Dietary Supplement Labeling Rules and the Possibility of Medical Cost Reduction.美国膳食补充剂标签规定与降低医疗成本的可能性。
J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S136-8. doi: 10.3177/jnsv.61.S136.
9
Dietary supplements: how they are used and regulated.膳食补充剂:其使用方式与监管情况
J Nutr. 2001 Mar;131(3s):1114S-7S. doi: 10.1093/jn/131.3.1114S.
10
Too little, too late: ineffective regulation of dietary supplements in the United States.太少,太迟:美国对膳食补充剂的监管不力。
Am J Public Health. 2015 Mar;105(3):478-85. doi: 10.2105/AJPH.2014.302348. Epub 2015 Jan 20.

引用本文的文献

1
Landscape of Herbal Food Supplements: Where Do We Stand with Health Claims?草本膳食补充剂的现状:我们在健康宣称方面处于何种境地?
Nutrients. 2025 May 2;17(9):1571. doi: 10.3390/nu17091571.
2
Traditional medicine regulation status and challenges in Malawi and Nigeria.马拉维和尼日利亚的传统医学监管现状与挑战。
BMC Complement Med Ther. 2025 Feb 14;25(1):53. doi: 10.1186/s12906-025-04812-2.
3
Lessons for cannabinoid regulation from electronic nicotine delivery system product regulation.电子尼古丁传送系统产品监管为大麻素监管带来的启示。
Health Aff Sch. 2024 Aug 16;2(8):qxae101. doi: 10.1093/haschl/qxae101. eCollection 2024 Aug.
4
Labeling compliance and online claims for Ayurvedic herbal supplements on the U.S. market associated with the purported treatment of COVID-19.美国市场上与声称可治疗新冠肺炎相关的阿育吠陀草药补充剂的标签合规情况及在线宣称
Food Control. 2023 Jun;148:109673. doi: 10.1016/j.foodcont.2023.109673. Epub 2023 Feb 6.
5
Japanese newspaper advertisements for dietary supplements before and after COVID-19: a content analysis.日本新冠肺炎疫情前后的膳食补充剂报纸广告:内容分析。
BMJ Open. 2021 Nov 23;11(11):e050898. doi: 10.1136/bmjopen-2021-050898.
6
A content analysis of marketing on the packages of dietary supplements for weight loss and muscle building.对减肥和增肌膳食补充剂包装上的营销内容分析。
Prev Med Rep. 2021 Jul 23;23:101504. doi: 10.1016/j.pmedr.2021.101504. eCollection 2021 Sep.
7
A Content Analysis of Video Advertisements for Dietary Supplements in Japan.日本膳食补充剂视频广告的内容分析
Healthcare (Basel). 2021 Jun 17;9(6):742. doi: 10.3390/healthcare9060742.
8
False and misleading health-related claims in food supplements on Spanish radio: an analysis from a European Regulatory Framework.食品补充剂在西班牙广播中的虚假和误导性与健康相关的声明:基于欧洲监管框架的分析。
Public Health Nutr. 2021 Oct;24(15):5156-5165. doi: 10.1017/S1368980021002007. Epub 2021 May 11.
9
Labeling of Cannabidiol Products: A Public Health Perspective.大麻二酚产品的标签:公共卫生视角
Cannabis Cannabinoid Res. 2020 Dec 15;5(4):274-278. doi: 10.1089/can.2019.0101. eCollection 2020.